WAM
ABBV icon

Walker Asset Management’s AbbVie ABBV Stock Holding History

Walker Asset Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$625K Buy
2,483
+19
+0.8% +$4.09K 0.32% 63
2026
Q1 		$536K Buy
2,464
+35
+1% +$7.76K 0.29% 66
2025
Q4 		$555K Buy
2,429
+17
+0.7% +$3.87K 0.3% 60
2025
Q3 		$559K Buy
2,412
+18
+0.8% +$3.67K 0.31% 57
2025
Q2 		$444K Buy
2,394
+21
+0.9% +$3.9K 0.26% 69
2025
Q1 		$497K Buy
2,373
+19
+0.8% +$3.69K 0.3% 58
2024
Q4 		$418K Buy
2,354
+20
+0.9% +$3.68K 0.26% 67
2024
Q3 		$461K Sell
2,334
-19
-0.8% -$3.55K 0.29% 58
2024
Q2 		$404K Buy
2,353
+21
+0.9% +$3.48K 0.27% 66
2024
Q1 		$425K Buy
2,332
+19
+0.8% +$3.27K 0.28% 58
2023
Q4 		$358K Buy
+2,313
New +$337K 0.26% 71

Other funds holding ABBV

LMFP
Larry Mathis Financial Planning Phoenix, Arizona $124B AUM
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
HCM
Hamlin Capital Management New York $4.45B AUM 22.95% 1-Year Est. Return
AAMU
AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return
HPC
HM Payson & Co Portland, Maine $7.54B AUM 31.34% 1-Year Est. Return
CRM
Cardano Risk Management Rotterdam, Netherlands $13B AUM 49.44% 1-Year Est. Return
CNB
Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Walker Asset Management's ABBV Position: Q2 2026 in Review

Walker Asset Management increased its AbbVie (ABBV) stake by 0.77% in Q2 2026, buying an estimated $4.09K and bringing the position to 2,483 shares worth $625K. The position accounts for 0.32% of the portfolio, ranked #63.

Walker Asset Management first reported a position in ABBV in Q4 2023 and has held it in 11 quarters since. 803 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Walker Asset Management held 2,483 shares of AbbVie worth $625K as of Q2 2026.
  • Walker Asset Management bought 19 AbbVie shares in Q2 2026, an estimated $4.09K.
  • AbbVie made up 0.32% of Walker Asset Management's portfolio in Q2 2026, its #63 holding.
  • Walker Asset Management first reported a position in AbbVie in Q4 2023 and has held it in 11 quarters since.
  • 803 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Walker Asset Management's 13F filing for Q2 2026, filed 10 Jul 2026.